InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (2 ops.)
Browse the full record of transactions filed by Johnson Brady, Chairman & CEO. Officer active across 1 companies, notably Cidara Therapeutics, Inc.. In total, 9 reports have been published. Total volume traded: €1k. The latest transaction was filed on 31 March 2022 — Attribution. Regulator: SEC (Form 4). The full history is accessible without signup.
Declarations9 total
010,000 shares0
Common Stock
SEC:0001610618-22-000031:0·
€480654 shares@ €0.733544.1% of flow
Common Stock
SEC:0001610618-22-000015:0·
€609945 shares@ €0.644655.9% of flow
Common Stock
SEC:0001610618-22-000013:0·
0262 shares0
Common Stock
SEC:0001209191-22-002602·
0262 shares0
Common Stock
SEC:0001209191-22-002602:0·
020,750 shares0
Common Stock
SEC:0001610618-21-000097·
020,750 shares0
Common Stock
SEC:0001610618-21-000097:0·
020,750 shares0
Common Stock
SEC:0001610618-21-000095·
020,750 shares0
Common Stock
SEC:0001610618-21-000095:0·
9 of 9 declarations
About Johnson Brady
Brady Johnson is the CEO of Cidara Therapeutics, Inc. He oversees the company's operations and is responsible for the overall strategy. With a strong background in the biopharmaceutical sector, Brady Johnson is committed to advancing Cidara Therapeutics, Inc.'s research and development initiatives to improve medical treatments.
